PRLD
Prelude Therapeutics (PRLD)
$32
About Prelude Therapeutics (PRLD)
Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.
Details
Daily high
$4.45
Daily low
$4.14
Price at open
$4.14
52 Week High
$5.54
52 Week Low
$0.75
Market cap
344.1M
Dividend yield
0.00%
Volume
296,671
Avg. volume
337,214
P/E ratio
-4.09
Prelude Therapeutics News
Details
Daily high
$4.45
Daily low
$4.14
Price at open
$4.14
52 Week High
$5.54
52 Week Low
$0.75
Market cap
344.1M
Dividend yield
0.00%
Volume
296,671
Avg. volume
337,214
P/E ratio
-4.09